DS
LinkedIn

Dr. Sven Dethlefs

President & CEO

Greater Philadelphia · 1 connection

Celea Therapeutics

Not on Unlinked · Imported profile. Is this you? Claim it

About

CEO of Celea Therapeutics. Executive roles at Teva Pharmaceuticals. Partner at McKinsey & Company. PhD in Biochemistry from the FU Berlin/Institute Pasteur Paris. Geographic experience: USA, Europe, International Markets (MEA, Latam, China, Japan, Korea) Industry coverage: Innovative medicines, Biosimilars, Gx and OTC

Experience

President & CEOCelea Therapeutics
Jul 2026
Member of The Supervisory BoardSynthon
Jun 2025
CEO Celea TherapeuticsPureTech Health
Aug 2025 to Jun 2026
Entrepreneur in ResidencePureTech Health
Apr 2024 to Aug 2025
CEO Teva North America | USA & CanadaTeva Pharmaceuticals
Aug 2021 to Mar 2024
CEO Teva International Markets and Global Head of Marketing & PortfolioTeva Pharmaceuticals
Apr 2021 to Aug 2021
Global Head of Marketing & PortfolioTeva Pharmaceuticals
Nov 2017 to Mar 2021
Global Head Respiratory MedicinesTeva Pharmaceuticals
Jan 2016 to Nov 2017
Chief Operating Officer | Teva Global OperationsTeva Pharmaceuticals
Oct 2013 to Dec 2015
General Manager Germany | Teva & ratiopharm GmbHTeva Pharmaceuticals
May 2008 to Sep 2013
PartnerMcKinsey & Company
Oct 1997 to Apr 2008
Military ServiceBundeswehr (German Federal Armed Forces)
Jul 1988 to Sep 1989

Education

Freie Universität Berlin
Dr.rer.nat/PhD, Biochemistry
1990 to 1997
Institute Pasteur Paris | France
PhD Research Immunology
1994 to 1997
Fondazione IRCCS Istituto Neurologico Carlo Besta Milan | Italy
Research Fellow Molecular Biology
1993 to 1994
University of Tübingen
Biochemistry
1989 to 1990